Have a personal or library account? Click to login
New markers of oxidative stress in lichen planus and the influence of hepatitis C virus infection – a pilot study Cover

New markers of oxidative stress in lichen planus and the influence of hepatitis C virus infection – a pilot study

Open Access
|Nov 2021

References

  1. 1. BETTERIDGE DJ. What Is Oxidative Stress? Metabolism. 2000;49:3–8.
  2. 2. BURTON GJ., JAUNIAUX E. Oxidative stress. Best Pract Res Clin Obstet Gynaecol. 2011;25:287–99.10.1016/j.bpobgyn.2010.10.016310133621130690
  3. 3. YOSHIKAWA T., NAITO Y. What Is Oxidative Stress? Japan Med Assoc J. 2002;45:271–6.
  4. 4. SHIRZAD A., POURAMIR M., SEYEDMAJIDI M., JENABIAN N., BIJANI A., MOTALLEBNEJAD M. Salivary Total Antioxidant Capacity and Lipid Peroxidation in Patients with Erosive Oral Lichen Planus. J Dent Res Dent Clin Dent Prospects. 2014;8:35–9.
  5. 5. SCHLOSSER BJ. Lichen planus and lichenoid reactions of the oral mucosa. Dermatol Ther. 2010;23:251–67.10.1111/j.1529-8019.2010.01322.x20597944
  6. 6. TAMPA M., CARUNTU C., MITRAN MI., MITRAN CI., SARBU MI., RUSU LC., et al. Markers of Oral Lichen Planus Malignant Transformation. Dis Markers. 2018;1959506:2018.10.1155/2018/1959506584645929682099
  7. 7. GEORGESCU SR., ENE CD., NICOLAE IL., MITRAN MI., MUSETESCU AL., MATEI C., et al. Reflectometric analysis for identification of various pathological conditions associated with lichen planus. Rev Chim. 2017;68:1103–8.10.37358/RC.17.5.5621
  8. 8. CARROZZO M., SCALLY K. Oral manifestations of hepatitis C virus infection. World J Gastroenterol. 2014;20:7534–43.10.3748/wjg.v20.i24.7534406928524976694
  9. 9. ROMERO MA., SEOANE J., VARELA-CENTELLES P., DIZ-DIOS P., OTERO XL. Clinical and pathological characteristics of oral lichen planus in hepatitis C-positive and -negative patients. Clin Otolaryngol Allied Sci. 2002;27:22–6.10.1046/j.0307-7772.2001.00516.x11903367
  10. 10. BĂLĂNESCU P., LĂDARU A., VOIOSU T., NICOLAU A., ENE M., BĂLĂNESCU E. Th17 and IL-17 immunity in chronic hepatitis C infection. Rom J Intern Med. 2012;50(1):13–8.
  11. 11. GEORGESCU SR., TAMPA M., MITRAN MI., MITRAN CI., SARBU MI., NICOLAE I., et al. Potential pathogenic mechanisms involved in the association between lichen planus and hepatitis C virus infection. Exp Ther Med. 2019;17:1045–51.
  12. 12. PAYERAS MR., CHERUBINI K., FIGUEIREDO MA., SALUM FG. Oral lichen planus: focus on etiopathogenesis. Arch Oral Biol. 2013;58:1057–69.10.1016/j.archoralbio.2013.04.00423660124
  13. 13. ALY DG., SHAHIN RS. Oxidative stress in lichen planus. Acta Dermatovenerol Alp Panonica Adriat. 2010;19:3–11.
  14. 14. MITRAN MI., NICOLAE I., ENE CD., MITRAN CI., MATEI C., ENE C., et al. Relationship between gamma-glutamyl transpeptidase activity and inflammatory response in lichen planus. Rev Chim. 2018;69:739–43.10.37358/RC.18.3.6189
  15. 15. PARACHA UZ., FATIMA K., ALQAHTANI M., CHAUDHARY A., ABUZENADAH A., DAMANHOURI G., et al. Oxidative stress and hepatitis C virus. Virol J. 2013;10:251.10.1186/1743-422X-10-251375157623923986
  16. 16. JANKOVIC A., SASO L., KORAC A., KORAC B. Relation of Redox and Structural Alterations of Rat Skin in the Function of Chronological Aging. Oxid Med Cell Longev. 2019;2471312:2019.10.1155/2019/2471312639387430906501
  17. 17. NICOLAE I., ENE CD., GEORGESCU SR., TAMPA M., MATEI C., CEAUSU E. Effects of UV Radiation and Oxidative DNA Adduct 8-hydroxy-2′-deoxiguanosine on the Skin Diseases. Rev Chim. 2014;65:1036–41.
  18. 18. PERLUIGI M., COCCIA R., BUTTERFIELD DA. 4-Hydroxy-2-nonenal., a reactive product of lipid peroxidation., and neurodegenerative diseases: a toxic combination illuminated by redox proteomics studies. Antioxid Redox Signal. 2012;17:1590–609.10.1089/ars.2011.4406
  19. 19. ŁUCZAJ W., GĘGOTEK A., SKRZYDLEWSKA E. Antioxidants and HNE in redox homeostasis. Free Radic Biol Med. 2017;111:87–101.10.1016/j.freeradbiomed.2016.11.033
  20. 20. ERGUN S., TROŞALA ŞC., WARNAKULASURIYA S., ÖZEL S., ÖNAL AE., OFLUOĞLU D. Evaluation of oxidative stress and antioxidant profile in patients with oral lichen planus: oxidative stress and antioxidant profile in OLP. J Oral Pathol Med. 2011;40:286–93.10.1111/j.1600-0714.2010.00955.x
  21. 21. SOHAL RS. Role of oxidative stress and protein oxidation in the aging process. Free Radic Biol Med. 2002;33:37–44.10.1016/S0891-5849(02)00856-0
  22. 22. OLIVA-DAMASO E., OLIVA-DAMASO N., RODRIGUEZ-ESPARRAGON F., PAYAN J., BAAMONDE-LABORDA E., GONZALEZ-CABRERA F. Asymmetric (ADMA) and Symmetric (SDMA) Dimethylarginines in Chronic Kidney Disease: A Clinical Approach. Int J Mol Sci. 2019;20(15):3668–75.10.3390/ijms20153668669635531357472
  23. 23. SEZER E., OZUGURLU F., OZYURT H., SAHIN S., ETIKAN I. Lipid peroxidation and antioxidant status in lichen planus. Clin Dermatol. 2007;32:430–4.10.1111/j.1365-2230.2007.02436.x17459065
  24. 24. KARAM BS., CHAVEZ-MORENO A., KOH W., AKAR JG., AKAR FG. Oxidative stress and inflammation as central mediators of atrial fibrillation in obesity and diabetes. Cardiovasc Diabetol. 2017;16:120.10.1186/s12933-017-0604-9562255528962617
  25. 25. GORRINI C., HARRIS IS., MAK TW. Modulation of oxidative stress as an anticancer strategy. Nat Rev Drug Discov. 2013;12:931–47.10.1038/nrd400224287781
  26. 26. BISWAS SK. Does the Interdependence between Oxidative Stress and Inflammation Explain the Antioxidant Paradox? Oxid Med Cell Longev. 2016;2016:1–9.
  27. 27. YAMANE D., MCGIVERN DR., WAUTHIER E., YI M., MADDEN VJ., WELSCH C., et al. Regulation of the hepatitis C virus RNA replicase by endogenous lipid peroxidation. Nat Med. 2014;20:927–35.10.1038/nm.3610412684325064127
  28. 28. AMARA A., CONSTANS J., CHAUGIER C., SEBBAN A., DUBOURG L., PEUCHANT E., et al. Autoantibodies to malondialdehyde-modified epitope in connective tissue diseases and vasculitides. Clin Exp Immunol. 1995;101:233–8.10.1111/j.1365-2249.1995.tb08344.x15532667544246
  29. 29. BARRERA G., PIZZIMENTI S., DAGA M., DIANZANI C., ARCARO A., CETRANGOLO GP., et al. Lipid peroxidation-derived aldehydes., 4-hydroxynonenal and malondialdehyde in aging-related disorders. Antioxidants. 2018;7:E102.10.3390/antiox7080102611598630061536
  30. 30. BREITZIG M., BHIMINENI C., LOCKEY R., KOLLIPUTI N. 4-Hydroxy-2-nonenal: A critical target in oxidative stress? Am J Physiol Cell Physiol. 2016;311:C537–43.10.1152/ajpcell.00101.2016512975027385721
  31. 31. SCHAUR RJ., SIEMS W., BRESGEN N., ECKL PM. 4-Hydroxy-nonenal – A bioactive lipid peroxidation product. Biomolecules. 2015;5:2247–337.10.3390/biom5042247469323726437435
  32. 32. PARADIS V., MATHURIN P., KOLLINGER M., IMBERT-BISMUT F., CHARLOTTE F., PITON A., et al. In situ detection of lipid peroxidation in chronic hepatitis C: correlation with pathological features. J Clin Pathol. 1997;50:401–6.10.1136/jcp.50.5.4014999429215123
  33. 33. KONISHI M., IWASA M., ARAKI J., KOBAYASHI Y., KATSUKI A., SUMIDA Y., et al. Increased lipid peroxidation in patients with non-alcoholic fatty liver disease and chronic hepatitis C as measured by the plasma level of 8-isoprostane. J Gastroenterol Hepatol. 2006;21:1821–5.10.1111/j.1440-1746.2006.04420.x17074020
  34. 34. MORIYA K., NAKAGAWA K., SANTA T., SHINTANI Y., FUJIE H., MIYOSHI H., et al. Oxidative stress in the absence of inflammation in a mouse model for hepatitis C virus-associated hepatocarcinogenesis. Cancer Res. 2001;61:4365–70.
  35. 35. TAIN Y., HSU C. Toxic Dimethylarginines: Asymmetric Dimethylarginine (ADMA) and Symmetric Dimethylarginine (SDMA). Toxins (Basel). 2017;9:92–6.10.3390/toxins9030092537184728272322
  36. 36. DINU L., ENE CD., NICOLAE I., TAMPA M., MATEI C., GEORGESCU SR. The serum levels of 8-hidroxy-deoxyguanosine under the chemicals influence. Rev Chim. 2014;65:1319–26.
  37. 37. PISOSCHI AM., POP A. The role of antioxidants in the chemistry of oxidative stress: A review. Eur J Med Chem. 2015;97:55–74.10.1016/j.ejmech.2015.04.04025942353
  38. 38. BARIKBIN B., YOUSEFI M., RAHIMI H., HEDAYATI M., RAZAVI SM., LOTFI S. Antioxidant status in patients with lichen planus. Clinical and Experimental Dermatology. Clin Dermatol. 2011;36:851–4.
  39. 39. BACCI C., VANZO V., FRIGO AC., STELLINI E., SBRICOLI L., VALENTE M. Topical tocopherol for treatment of reticular oral lichen planus: A randomized., double-blind., crossover study. Oral Dis. 2017;23:62–8.10.1111/odi.1257327543905
  40. 40. HASHEMY SI., GHARAEI S., VASIGH S., KARGOZAR S., ALIREZAEI B., KEYHANI FJ, et al. Oxidative stress factors and C-reactive protein in patients with oral lichen planus before and 2 weeks after treatment. J Oral Pathol Med. 2016;45:35-40.10.1111/jop.1232626058710
DOI: https://doi.org/10.2478/rjim-2021-0017 | Journal eISSN: 2501-062X | Journal ISSN: 1220-4749
Language: English
Page range: 359 - 368
Submitted on: Nov 22, 2020
Published on: Nov 20, 2021
Published by: N.G. Lupu Internal Medicine Foundation
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2021 Madalina Irina Mitran, Mircea Tampa, Ilinca Nicolae, Cristina Iulia Mitran, Clara Matei, Simona Roxana Georgescu, Mircea Ioan Popa, published by N.G. Lupu Internal Medicine Foundation
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.